Harold W. de Valk

5.6k citations

117 papers · 3.4k indexed · 2 hit papers · h-index 34

Obstetrics and Gynecology top 0.5%
- Gestational Diabetes Research and Management 37
- Pregnancy and preeclampsia studies 12
Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research 47
- Diabetes Treatment and Management 25
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 15
Clinical Biochemistry top 1%
Pediatrics, Perinatology and Child Health top 2%
- Birth, Development, and Health 10
Internal Medicine top 5%
Genetics
- Diabetes and associated disorders 15
Surgery
- Bariatric Surgery and Outcomes 11

Co-authors: Gerard H.A. Visser Inge M. Evers Anneloes Kerssen Jan Westerink Marieke de Vries D.W. Erkelens Francjan J. van Spronsen M. Castro Cabezas
Cited by: Obstetrics and Gynecology Endocrinology, Diabetes and Metabolism Clinical Biochemistry
Journals: Journal of Clinical Investigation (1 paper)Annals of Internal Medicine (1 paper)PLoS ONE (1 paper)
Partner nations: Netherlands United Kingdom Germany

In The Last Decade

Harold W. de Valk

112 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Harold W. de Valk

Since Specialization

Citations

This map shows the geographic impact of Harold W. de Valk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold W. de Valk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold W. de Valk more than expected).

Fields of papers citing papers by Harold W. de Valk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold W. de Valk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold W. de Valk. The network helps show where Harold W. de Valk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Harold W. de Valk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harold W. de Valk Line = papers co-authored together Harold W. de Valk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	28 Oral antihyperglycemic agent strategy versus insulin for gestational diabetes mellitus – a randomized controlled trial American Journal of Obstetrics and Gynecology ·Doortje Rademaker,Leon de Wit,Ruben G. Duijnhoven,Daphne N. Voormolen-van Münster,Joris van der Post,Judith E. Bosmans,Harold W. de Valk,Inge M. Evers,Ben Willem W. Mol,Arie Franx,H. de Vries,Rebecca C. Painter,Bas B. van Rijn	2024	1
2	Association of physical activity and sports participation with insulin resistance and non‐alcoholic fatty liver disease in people with type 1 diabetes Diabetic Medicine ·Marieke de Vries,Jan Westerink,H. A. H. Kaasjager,Harold W. de Valk,(unknown)	2024	2
3	Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease Internal and Emergency Medicine ·Anne M. van Dijk,Marieke de Vries,Fatima El-Morabit,Simon Bac,Marco W. Mundt,L. E. van der Schuit,Meike M. Hirdes,Melih Kara,Joep de Bruijne,Skadi van der Meer,H. A. H. Kaasjager,Harold W. de Valk,Frank P. Vleggaar,Karel J. van Erpecum	2023	3
4	Continuous glucose monitoring metrics and pregnancy outcomes in insulin‐treated diabetes: A post‐hoc analysis of the GlucoMOMS trial Diabetes Obesity and Metabolism ·Doortje Rademaker,Anne W. T. van der Wel,Rik van Eekelen,Daphne N. Voormolen,Harold W. de Valk,Inge M. Evers,Ben W. Mol,Arie Franx,Sarah E. Siegelaar,Bas B. van Rijn,J. Hans DeVries,Rebecca C. Painter,(unknown)	2023	11
5	Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes European Journal of Internal Medicine ·Marieke de Vries,Fatima El-Morabit,Karel J. van Erpecum,Jan Westerink,Simon Bac,H. A. H. Kaasjager,Harold W. de Valk	2022	24
6	Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes European Journal of Endocrinology ·Marga A. G. Helmink,Marieke de Vries,Frank L.J. Visseren,Wendela L. de Ranitz,Harold W. de Valk,Jan Westerink	2021	27
7	Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis The Journal of Clinical Endocrinology & Metabolism ·Marieke de Vries,Jan Westerink,Karin Kaasjager,Harold W. de Valk	2020	95
8	Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes Diabetes Technology & Therapeutics ·Harold W. de Valk,Sandrine Lablanche,Emanuele Bosi,Pratik Choudhary,Julien Da Silva,Javier Castañeda,Linda Vorrink,Simona de Portu,Ohad Cohen	2018	6
9	A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes Diabetologia ·Aoife M. Egan,Sander Galjaard,Michael Maresh,Mary R. Loeken,Angela Napoli,Eleni Anastasiou,Eoin Noctor,Harold W. de Valk,Mireille N. M. van Poppel,Marie Todd,Valerie Smith,Declan Devane,Fidelma Dunne	2017	35
10	Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients PLoS ONE ·Gerdien Belle–van Meerkerk,Pim A. de Jong,Harold W. de Valk,Tim Neefjes,Frank A. Pameijer,Johanna M. Kwakkel‐van Erp,Ed A. van de Graaf	2015	6
11	Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis Orphanet Journal of Rare Diseases ·Martijn J. de Groot,Marieke Hoeksma,Dirk‐Jan Reijngoud,Harold W. de Valk,Anne M. J. Paans,Pieter J. J. Sauer,Francjan J. van Spronsen	2013	35
12	Advanced Glycation End Products, Measured as Skin Autofluorescence, During Normal Pregnancy and Pregnancy Complicated by Diabetes Mellitus Diabetes Technology & Therapeutics ·Wendela L. de Ranitz‐Greven,Lotte Kaasenbrood,Wendy K. Poucki,Jeanette Hamerling,Dieuwke C. Bos,Gerard H.A. Visser,Douwe H. Biesma,Joline W. J. Beulens,Harold W. de Valk	2012	16
13	The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder Schizophrenia Research ·Hanneke Welie,Eske M. Derks,Kim Verweij,Harold W. de Valk,René S. Kahn,Wiepke Cahn	2012	29
14	Gestational diabetes mellitus diagnosed by screening or symptoms: does it matter? The Journal of Maternal-Fetal & Neonatal Medicine ·Nurah M. Hammoud,Harold W. de Valk,Douwe H. Biesma,Gerard H.A. Visser	2012	8
15	Advanced Glycation End Products, Measured as Skin Autofluorescence, at Diagnosis in Gestational Diabetes Mellitus Compared with Normal Pregnancy Diabetes Technology & Therapeutics ·Wendela L. de Ranitz‐Greven,Dieuwke C. Bos,Wendy K. Poucki,Gerard H.A. Visser,Joline W. J. Beulens,Douwe H. Biesma,Harold W. de Valk	2011	15
16	Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review Diabetes Technology & Therapeutics ·Dieuwke C. Bos,Wendela L. de Ranitz‐Greven,Harold W. de Valk	2011	72
17	Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A_1cvalues in the first trimester of pregnancy The Journal of Maternal-Fetal & Neonatal Medicine ·Anneloes Kerssen,Inge M. Evers,Harold W. de Valk,Gerard H.A. Visser	2003	41
18	Een kinderziekte op de volwassen leeftijd: fenylketonurie Data Archiving and Networked Services (DANS) ·Harold W. de Valk,(unknown),Melissa Duran,Bwee Tien Poll‐The,D.W. Erkelens	2000	1
19	Effect of an increase in the plasma potassium concentration on renal magnesium handling in healthy volunteers Nephrology Dialysis Transplantation ·Harold W. de Valk,H.J.M. van Rijn,Jos P.M. Wielders,H A Koomans	1998	0
20	Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. Journal of Clinical Investigation ·M. Castro Cabezas,T W de Bruin,Harold W. de Valk,Carol C. Shoulders,Hans Jansen,D.W. Erkelens	1993	173

About Harold W. de Valk

Harold W. de Valk is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 117 papers that have together received 3.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (47 papers), Gestational Diabetes Research and Management (37 papers), Diabetes Treatment and Management (25 papers), Diabetes and associated disorders (15 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (15 papers), Pregnancy and preeclampsia studies (12 papers), Bariatric Surgery and Outcomes (11 papers) and Birth, Development, and Health (10 papers). The work is most often cited by research in Obstetrics and Gynecology (1.2k citations), Endocrinology, Diabetes and Metabolism (1.5k citations) and Clinical Biochemistry (277 citations). Harold W. de Valk has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Gerard H.A. Visser, Inge M. Evers, Anneloes Kerssen, Jan Westerink, Marieke de Vries, D.W. Erkelens, Francjan J. van Spronsen, M. Castro Cabezas, Carol C. Shoulders and Hans Jansen. Their work appears in journals such as Journal of Clinical Investigation, Annals of Internal Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact